Immunotherapy & Oncology
Cancer treatment has moved from poisoning dividing cells towards directing the immune system at the tumour, and towards drugs that carry their payload only to cancerous tissue. It absorbs more drug development spending than any other area.
388 stocks
New
Increased
Maintained
Reduced
Closed
Funds Holding
3,876
Funds Holding Change
+36
Funds Holding Growth
+0.9%
Value
$1.26T
Holding in Top 10
1,249
Top 10 Change
-161
Top 10 Growth
-11%
Value Growth
+16%
New
155
Increased
2,115
Reduced
1,413
Closed
80
Capital Inflow
$62.9B
Capital Outflow
$28.8B
Net Capital Flow
+$34.1B
Capital Flow Change
+$30.8B
Calls
$13.7B
Puts
$14.2B
Net Calls
-$461M
Put/Call Ratio
1.03